source
- Melanoma patient shares hope after receiving Merck-Moderna mRNA cancer vaccine in trialA schoolteacher diagnosed with melanoma in 2019 participated in a late‑stage trial testing an mRNA cancer vaccine developed by Merck and Moderna. The trial added the vaccine to standard immunothera…
- Kenya confirms second Ebola case as Congo outbreak continuesKenya health officials have confirmed a second case of Ebola in the country, raising concerns about potential spread. The report comes as the neighboring Democratic Republic of Congo continues to…